Professional Documents
Culture Documents
Figure: (2) = slow calcium channel, dCa+2 =
depolarizing calcium, (3) = Ca+2-pump (active
transport), (4) = Na+-Ca+2 Exchanger, aCa+2 =
activator calcium.
Factors that affect cardiac contractility:
Mechanical
Cardiac
Extra cardiac
Mechanical factors:
• Neural
• Physical
• Chemical
Neural factors:
Sympathetic stimulation and noradrenaline exert a
+ve inotropic eff¬ect by increasing;
•Cyclic-AMP in the cardiac muscle fibres (which
leads to activation of the Ca+2 channels and more
Ca+2 influx from the ECF).
•The heart rate.
Conversely, parasympathetic stimulation and
acetylcholine exert a -ve inotropic effect (by
opposite mechanism) but on the atrial muscle only
(since the vagi nerves don't supply the ventricles).
Physical factors:
A moderate rise of the body temperature
strengthens cardiac contractility (by increasing
the Ca+2 influx and ATP formation in the
muscle) while an excessive rise of the body
temperature (e.g. in fever) exhausts the
metabolic substrates in the cardiac muscle and
decreases its contractility. Hypothermia also
decreases cardiac contractility.
Chemical factors:
(A) Hormones:
Catecholamines (epinephrine, norepinephrine and dopamine),
glucagon and the thyroid hormones; all exert a +ve inotropic
effect.
(B) Blood gases:
Moderate hypoxia (O2 lack) and hypercapnia (CO2 excess)
increase the cardiac contractility, whereas severe hypoxia and
hyper¬capnia directly depress the cardiac muscle and
decrease its contractility.
(C) H + ion concentration (pH):
An increase of the blood [H+] i.e. drop of the blood pH
(acidosis) produces a -ve inotropic effect, whereas a
decrease of the blood [H+] i.e. rise of the blood pH (alkalosis)
produces a + ve inotropic effect
D) Inorganic ions:
•Sodium: Hypernatraemia favors Na+ influx and Ca+2 efflux by the
Na+-Ca+2 exchanger carrier, thus it has a -ve inotropic effect. On
the other
hand, hyponatraemia exerts a +ve inotropic effect by an opposite
mechanism.
•Potassium: Hyperkalaemia has a -ve inotropic effect (weakens the
myocardial contractility; flaccidity) and may stop the heart in
diastole. This is because the excess K+ in the ECF decreases the
resting membrane potential (more positive resting membrane
potential; closer to the threshold)) in the cardiac muscle fibers, so
the amplitude of the action potential is reduced leading to less
influx of the depolarizing Ca+2 and in turn less release of activator
Ca+2 from the sarcoplasmic reticulum. In addition, Hyperkalaemia
increases excitation and decreases conduction leading to ectopics
and dilated, flaccid heart. On the other hand, hypokalaemia
produces a +ve inotropic effect by an opposite mechanism.
•Calcium: Hypercalcaemia exerts a +ve inotropic effect as a result
of more cytosolic Ca+2. Whereas hypocalcaemia has a little (or no) -
ve inotropic effect, since lowering of the serum Ca+2 level causes
fatal tetany before affecting the heart. However, hypocalcaemia
causes cardiac flaccidity like Hyperkalaemia.
E) Toxins:
Several toxins (e.g. certain snake venoms and the toxin released by
the diphtheria microorganisms) produce a-ve inotropic effect
(mostly by a direct action on the contractile mechanism of the
cardiac muscle).
(F) Drugs:
•Cardiac glycosides (e.g. digitalis; Digoxin): These drugs inhibit the
Na+-K+ ATPase in the sarcolemma of the cardiac muscle fibres, so
the intracellular Na+ concentration increases. This decrease the
Na+ influx, thus Ca+2 efflux through the Na+-Ca+2 exchanger is
also decreased. Accordingly, the intra-cellular Ca+2 concentration
increases, producing a +ve inotropic effect. Digitalis also increases
the slow Ca+2 influx during the action potential.
•Xanthines (e.g., caffeine and theophylline; bronchodilator): They
exert a +ve inotropic effect.
•Ouinidine, barbiturates, procainamide (and other anesthetic drugs)
as well as Ca+2 blocker drugs all have a -ve inotropic effect by
decreasing Ca+2 influx into the cardiac muscle fibres.